Paeds Vivas · child-safety-and-social-paediatrics
Medical neglect and refusal of care — branching viva
Branching viva on the omission-versus-rejection definitions, the Diekema harm-principle threshold, the four classic refusal scenarios (vaccines, vitamin K, Jehovah's Witness blood transfusion, cancer chemotherapy), separating access-based neglect from deliberate refusal, the stepped negotiate-to-escalate management, the mature-minor doctrine, and a safeguarding conversion.
On this page & tools
Target exams
Stem
The examiner opens with a 4-year-old with newly diagnosed acute lymphoblastic leukaemia whose parents refuse chemotherapy, then escalates through the definitions, the Diekema harm-principle threshold, the separation of access-based neglect from deliberate refusal, the stepped negotiate-to-escalate management, the specific refusal scenarios, and a twist involving a competent adolescent. [1] [9]
Branch 1 — Definitions and classification
Examiner: A 4-year-old is newly diagnosed with ALL. The cure rate with standard chemotherapy exceeds ninety per cent. His parents decline chemotherapy and plan to use herbal remedies. They are loving, attentive, and face no barriers. What is the frame, and is this neglect or refusal? [2]
Strong answer: The frame is the clinical-ethics interface of unmet medical need and parental authority. Medical neglect is the failure of a caregiver to seek, attend to, or comply with medically necessary treatment — a passive omission, often driven by access barriers, capacity limitation, or overwhelm. Refusal of care is the active, deliberate rejection of recommended treatment on religious, ideological, or personal grounds. This family is refusal, not access-based neglect, because they understand the diagnosis and treatment, face no poverty or barrier, and have made an explicit decision to reject the only effective therapy. The distinction matters because the first response to access-based neglect is support and advocacy, while the first response to deliberate refusal is negotiation and possible escalation. [2] [3]
Examiner: Name the four classic refusal scenarios. [7]
Strong answer: Vaccines — the most common, driven by ideology, with real population-level harm demonstrated by Phadke. Neonatal vitamin K — tracked alongside vaccine refusal, with the late VKDB intracranial haemorrhage risk shown by Sahni. Jehovah's Witness blood transfusion — religious refusal of blood products in the face of life-threatening anaemia or haemorrhage, described by Conti. And cancer chemotherapy — rare but devastating, where a ninety per cent curable disease becomes uniformly fatal, as shown by Caruso Brown's systematic review. [7] [8] [9]
Branch 2 — The Diekema harm-principle threshold
Examiner: What threshold determines when you override parental refusal? [1]
Strong answer: The Diekema harm-principle threshold, published in 2004 in Theoretical Medicine and Bioethics. The state should intervene to override parental refusal of medical treatment when four conditions are met: the child is at significant risk of serious harm; the harm is imminent; the recommended intervention is likely to be effective; and the burden of the intervention is proportionate. Below that threshold, parental authority and religious freedom hold. Above it, the clinician has a duty to seek a court order or child-protection intervention. This is the central organising principle for the entire topic, and naming it is what separates a pass from a distinction. [1]
Examiner: Apply it to the child with ALL. [1]
Strong answer: First, the child is at significant risk of serious harm — untreated ALL is uniformly fatal. Second, the harm is imminent — the induction window is narrow and the disease progresses within weeks. Third, the intervention is highly effective — a cure rate above ninety per cent. Fourth, the burden is proportionate — the side effects are real but time-limited and far outweighed by the alternative of death. All four conditions are met, the threshold is crossed, and I negotiate first but escalate to a court order if negotiation fails. [1] [9]
Branch 3 — Separating access-based neglect from refusal
Examiner: A family misses three consecutive asthma clinic appointments, the preventer is never collected, and the child has recurrent admissions. How do you separate access barriers from deliberate refusal? [4]
Strong answer: I explore the mechanism and the caregiving response with a curious, non-blaming stance. Can they afford the prescription and the transport? Do they understand what the preventer does and why daily adherence matters? Is there a language barrier, a health-literacy gap, or a chaotic home? If the gap is access-driven — poverty, transport, health literacy, or system failure — the response is support: care coordination, prescription assistance, transport, a health-literacy-informed explanation, and a medical home that holds the long view. If the family actively rejects the treatment when it is offered and explained, it is refusal. The two can coexist, and the supportive response and the protective response can run together — but I never treat access barriers as deliberate non-compliance, because poverty is not neglect. [4] [5]
Examiner: And the classic error in the other direction? [1]
Strong answer: Under-calling medical neglect by attributing a chronic pattern of unmet need to a single difficult period or a cultural difference — that leaves a child exposed. When the mechanism and the caregiving response tell different stories, I gather multi-source information — the GP record, the hospital record, the prescription-dispensing record, the immunisation history — to assemble the pattern across settings before settling. The two mirror-image errors are over-calling in poverty, which stigmatises and fails to help, and under-calling, which fails to protect. [1]
Branch 4 — Stepped management
Examiner: Outline your stepped management of the ALL refusal. [9]
Strong answer: Step 1 — recognise and assess harm: confirm the diagnosis and prognosis, apply the Diekema threshold, and document the family's understanding. Step 2 — engage and negotiate: explore their specific fears, provide clear information about survival rates and side effects, involve the oncology team and a hospital ethicist, address misconceptions, and offer time — Caruso Brown's review showed most families who initially refuse will accept treatment after negotiation, ethics consultation, and time. Step 3 — escalate if negotiation fails and the threshold is met: seek an urgent court order for treatment under parens patriae jurisdiction, make a mandatory child-protection report, and treat under the order while supporting the family throughout. In an emergency, treat under the doctrine of necessity. Step 4 — follow up with a named lead and return precautions, because the file is never closed on a single conversation. [1] [9]
Examiner: Why must you negotiate first rather than reaching straight for a court order? [12]
Strong answer: Because most refusals are resolved through respectful, informed conversation, and a clinician who reaches for a court order without attempting negotiation has not met the standard. Salter and Hester's consensus recommendations integrate the best-interests standard with the harm threshold and emphasise that negotiation, ethics consultation, and time are both ethically sound and clinically effective — the prognosis is better when the family feels respected rather than coerced. Negotiation and escalation are not opposites; the first is attempted before the second, and both serve the same goal of ensuring the child receives the treatment they need. [3] [12]
Branch 5 — The mature-minor twist
Examiner: The 15-year-old sibling is now diagnosed with Hodgkin lymphoma, with a cure rate above ninety per cent. She refuses chemotherapy herself. Can you respect her refusal? [10]
Strong answer: Coleman and Rosoff established that competent adolescents may have the legal authority to consent to or refuse general medical treatment in many jurisdictions. I assess competence first: does she understand the condition, the treatment, the consequences of refusal, and the alternatives? If competent, her refusal carries weight — but the threshold for overriding an adolescent's refusal of life-saving treatment is lower than for an adult. Courts weigh her developing autonomy against the gravity and irreversibility of the harm, the presumption of future competence, and the fact that she has not yet had the chance to form mature values. For curative chemotherapy with a high cure rate, the irreversibility of death weighs heavily toward intervention. I involve ethics, legal, and mental-health teams, assess for coercion or untreated mental illness, and if the refusal persists and the threshold is met, I seek a court order — but I engage her as a partner throughout, because her voice matters even when it is overridden. [10]
Examiner scoring cues
- Defines medical neglect as omission and refusal of care as active rejection, and separates the two using the mechanism and the caregiving response. [2] [3]
- Quotes the four-condition Diekema harm-principle threshold by name and applies it to the scenario. [1]
- Names the four classic refusal scenarios — vaccines, vitamin K, Jehovah's Witness blood, cancer chemotherapy — with the evidence anchors. [7] [9]
- Separates access-based neglect from deliberate refusal, and commits to addressing material barriers rather than labelling poverty as non-compliance. [4] [5]
- Negotiates first, escalates to a court order only when the threshold is met, and never closes the file on a single conversation. [12]
- Treats the emergency first under the doctrine of necessity while the legal and ethical discussion runs alongside. [6]
- Assesses adolescent competence and articulates the lower threshold for overriding refusal of life-saving treatment in a minor. [10]
References
- [1]Diekema DS Parental refusals of medical treatment: the harm principle as threshold for state intervention. Theor Med Bioeth, 2004.PMID 15637945
- [2]Jenny C, American Academy of Pediatrics Committee on Child Abuse and Neglect Recognizing and responding to medical neglect. Pediatrics, 2007.PMID 18055690
- [3]Boos SC, Fortin K Medical neglect. Pediatr Ann, 2014.PMID 25369577
- [4]Ward MGK, Baird B Medical neglect: Working with children, youth, and families. Paediatr Child Health, 2022.PMID 36200106
- [5]Dubowitz H Neglect in children. Pediatr Ann, 2013.PMID 23556521
- [6]Conti A, Capasso E, Casella C, et al. Blood transfusion in children: the refusal of Jehovah's Witness parents. Open Med (Wars), 2018.PMID 29666843
- [7]Phadke VK, Bednarczyk RA, Salmon DA, et al. Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis. JAMA, 2016.PMID 26978210
- [8]Sahni V, Lai FY, MacDonald SE Neonatal vitamin K refusal and nonimmunization. Pediatrics, 2014.PMID 25136042
- [9]Caruso Brown AE, Slutzky AR Refusal of treatment of childhood cancer: a systematic review. Pediatrics, 2017.PMID 29146622
- [10]Coleman DL, Rosoff PM The legal authority of mature minors to consent to general medical treatment. Pediatrics, 2013.PMID 23530175
- [12]Salter EK, Hester DM, Vinarcsik L, et al. Pediatric decision making: consensus recommendations. Pediatrics, 2023.PMID 37555276